The Tempus AI, Inc. (NASDAQ: TEM) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Tempus is a healthcare technology company that applies artificial intelligence and multimodal data to precision medicine, and its filings offer insight into how it reports financial performance, manages capital, and documents material corporate events.
Investors can review Form 8-K filings where Tempus discloses items such as preliminary financial results, earnings press releases, credit agreement amendments, securities offerings, and other significant developments. For example, Tempus has used 8-K reports to furnish quarterly financial information, describe an automatic shelf registration statement and related prospectus supplement, and detail the terms of its convertible senior notes due 2030, including conversion features, redemption provisions, and associated capped call transactions.
Over time, this page will also surface Tempus’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for its Diagnostics and Data and applications businesses, risk factor discussions, and management’s analysis of operations. In addition, users can expect access to ownership and insider transaction disclosures, such as Form 4 filings, when they are available from EDGAR.
Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings in clear language. Real-time updates from EDGAR help ensure that new TEM filings appear promptly, while AI-generated highlights can draw attention to important terms in credit agreements, securities offerings, or covenant changes. This combination allows readers to navigate Tempus’s regulatory history more efficiently, from capital structure details to ongoing financial reporting.
Tempus AI, Inc. (TEM) received a Rule 144 notice from officer Thomas Schoenherr regarding planned sales of common stock. Schoenherr intends to sell 2,694 shares of common stock, held in connection with Performance Stock Units, through Morgan Stanley Smith Barney LLC. The notice also reports prior sales over the past three months, including 8,082 shares on August 19, 2026 and 9,232 shares on August 18, 2026, both of Tempus AI common stock. These transactions relate to Schoenherr’s personal holdings and do not represent a new issuance of shares by Tempus AI.
Tempus AI, Inc. (TEM) reported that officer Ryan Fukushima, CEO, Data, had 41,095 shares of Class A Common Stock sold on 2026-08-18 in a broker transaction at a weighted average price of $49.61 per share. According to the company’s equity incentive plan, this was a mandatory “sell to cover” trade solely to satisfy minimum statutory tax withholding obligations arising from restricted stock unit vesting and is described as not a discretionary sale by the reporting person. Following this transaction, he held 562,463 shares directly, and a further 61,706 shares indirectly reported as held by his spouse.
Tempus AI, Inc. (TEM) reported that CEO and Chairman Eric P. Lefkofsky sold 132,591 shares of Class A Common Stock on August 18, 2026 at a weighted average price of $49.61 per share, in a sale mandated to cover statutory tax withholding obligations arising from RSU vesting, not a discretionary sale. After this transaction, he holds 2,098,130 shares directly and reports additional indirect holdings, including 8,717,783 shares held by Gray Media, LLC and 15,255,469 shares held by Blue Media, LLC, as well as further foundation and GRAT positions.
Tempus AI, Inc. (TEM) reported that Thomas Edward Schoenherr, CEO, Diagnostics, sold an aggregate of 17,314 shares of Class A Common Stock in seven open-market transactions on August 18–19, 2026. One block of 9,232 shares on August 18, 2026 was sold to cover minimum statutory tax withholding obligations upon vesting of restricted stock units and is described as not a discretionary sale. The August 19, 2026 sales were executed under a Rule 10b5-1 trading plan adopted on March 3, 2026.
Tempus AI, Inc. (TEM) reported that Chief Financial Officer James William Rogers disclosed two sales of Class A Common Stock. On August 18, 2026, he sold 22,529 shares at a weighted average price of $49.61 in a mandated "sell to cover" transaction to satisfy statutory tax withholding on RSU vesting, which the company notes was not a discretionary sale. On August 19, 2026, he sold 26,313 shares at $60.00 per share in open-market transactions made pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2025. In total, 48,842 shares were sold across the two days.
Tempus AI, Inc. (TEM) executive Andrew Polovin, EVP and Chief Legal Officer, reported two open-market sales of Class A Common Stock. On August 18, 2026, he sold 22,148 shares at a weighted average price of $49.61 in multiple trades from $49.35–$49.99 to cover minimum statutory tax withholding on vested restricted stock units under a mandatory "sell to cover" arrangement, which the company characterizes as non-discretionary. On August 19, 2026, he sold 7,927 shares at $56.00 per share in a sale made pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2025. In total, 30,075 shares were sold in these transactions.
Tempus AI, Inc. (TEM) reported that Chief Accounting Officer Ryan M. Bartolucci disposed of 6,175 shares of Class A Common Stock on 2026-08-18 at a weighted average price of $49.61 per share. According to the company’s equity plan, this was a mandatory “sell to cover” transaction to satisfy statutory tax withholding obligations upon vesting of restricted stock units and is not a discretionary sale by the officer. After this sale, Bartolucci directly holds 67,866 shares of Tempus AI Class A Common Stock. The shares were sold in multiple trades at prices ranging from $49.35 to $49.99 per share.
Tempus AI, Inc. (TEM) is the issuer of Class A common stock for which Eric Paul Lefkofsky has filed a notice under Rule 144 to sell up to 132,591 shares through Morgan Stanley Smith Barney LLC. The notice ties part of the shares to restricted stock units and performance stock units previously granted by Tempus AI. It also lists multiple sales of Tempus AI Class A shares in the past three months by entities associated with Lefkofsky, including Blue Media, LLC, Gray Media, LLC, Lefkofsky Family Foundation, and Vas.org Foundation. The notice states that the reported sales are mandated sell-to-cover transactions to satisfy tax withholding obligations under Tempus AI’s equity incentive plan rather than discretionary trades by Lefkofsky.
Tempus AI, Inc. (TEM) received a Rule 144 notice from officer Andrew Polovin regarding planned sales of Class A common stock. The notice lists 22,148 shares of Class A common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 08/18/2026.
The securities relate to multiple equity awards from Tempus AI, including restricted stock units granted between 2022 and 2024 and performance stock units granted in 2025, with individual award amounts such as 1,696, 2,883, and 15,358 shares. The filing states that the sales are mandated under the company’s equity incentive plan to satisfy tax withholding obligations via sell-to-cover transactions and do not represent discretionary trades by Polovin.
Tempus AI, Inc. (TEM) received a Rule 144 notice from officer Ryan Fukushima covering potential sales of its Class A common stock. The notice relates to 41,095 shares, with an indicated aggregate market value of $2,122,145.80 and shows 175,390,967 shares of Class A common stock outstanding. The filing lists underlying awards including Restricted Stock Units and Performance Stock Units granted between 2022 and 2026. Disclosed sales during the past three months under 10b5-1 plans for another participant, Vanessa Kubo, total several tranches of Class A common stock. Tempus AI states the reported sales are mandated "sell to cover" transactions under its equity incentive plan to satisfy tax withholding obligations and are not discretionary trades by the reporting person.